Web Exclusives

Could innovation (true and urgent cross-sector partnership-led innovation) really be the key to tackling the world’s major global health pandemics?

Second medical use patents have taken a blow with the Supreme Court’s recent ruling in Warner-Lambert v Mylan and Actavis.

For pharmaceutical and life sciences firms, a case-by-case approach to information and content management has been prevalent for too long

We spoke to Medidata’s General Manager and Senior Vice President EMEA Christian Hebenstreit at the New York NEXT conference to find out how virtual trials could change R&D

Tips for becoming compliant

London leads this increasingly important study by a huge margin, finds new study

A review of the UK Bribery Act could mean pharma needs to adapt to changes in legislation

How pharma companies are starting to lead the change in workplace mental health

What the proposed changes to the National Institutes of Health Recombinant DNA Advisory Committee mean for patients and drug developers

Evolving the pharma value proposition

Aaron Hudson from SCIEX provides insight on the potential impact of genetic and non-genetic biomarkers for precision medicine

The biopharmaceutical industry is finally embracing a continuous approach to medicine manufacturing, and we’re already experiencing the benefits

A fully digital NHS should be close to reality, but it’s a challenge that many hospitals are not ready to take on

Five steps to overcome challenges presented in pharmaceutical sales

In today’s trade environment, efficient screening is virtually impossible without IT support